These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

987 related items for PubMed ID: 19596921

  • 1. Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease.
    Safranek J, Pesta M, Holubec L, Kulda V, Dreslerova J, Vrzalova J, Topolcan O, Pesek M, Finek J, Treska V.
    Anticancer Res; 2009 Jul; 29(7):2513-7. PubMed ID: 19596921
    [Abstract] [Full Text] [Related]

  • 2. Expression of mRNA MMP-7 and mRNA TIMP-1 in non-small cell lung cancer.
    Safranek J, Holubec L, Topolcan O, Pesta M, Klecka J, Vodicka J, Finek J, Kormunda S, Pesek M.
    Anticancer Res; 2007 Jul; 27(4C):2953-6. PubMed ID: 17695477
    [Abstract] [Full Text] [Related]

  • 3. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
    Gouyer V, Conti M, Devos P, Zerimech F, Copin MC, Créme E, Wurtz A, Porte H, Huet G.
    Cancer; 2005 Apr 15; 103(8):1676-84. PubMed ID: 15754326
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples.
    Pesta M, Holubec L, Topolcan O, Cerna M, Rupert K, Holubec LS, Treska V, Kormunda S, Elgrova L, Finek J, Cerny R.
    Anticancer Res; 2005 Apr 15; 25(5):3387-91. PubMed ID: 16101153
    [Abstract] [Full Text] [Related]

  • 6. Clinicopathological assessment and quantitative estimation of the matrix metalloproteinases MMP-2 and MMP-7 and the inhibitors TIMP-1 and TIMP-2 in colorectal carcinoma tissue samples.
    Pesta M, Topolcan O, Holubec L, Rupert K, Cerna M, Holubec LS, Treska V, Finek J, Cerny R.
    Anticancer Res; 2007 Apr 15; 27(4A):1863-7. PubMed ID: 17649785
    [Abstract] [Full Text] [Related]

  • 7. Simultaneous measurement of MMP9 and TIMP1 mRNA in human non small cell lung cancers by multiplex real time RT-PCR.
    Simi L, Andreani M, Davini F, Janni A, Pazzagli M, Serio M, Orlando C.
    Lung Cancer; 2004 Aug 15; 45(2):171-9. PubMed ID: 15246188
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
    Ylisirniö S, Höyhtyä M, Turpeenniemi-Hujanen T.
    Anticancer Res; 2000 Aug 15; 20(2B):1311-6. PubMed ID: 10810441
    [Abstract] [Full Text] [Related]

  • 10. Elevated levels of circulating plasma matrix metalloproteinase 9 in non-small cell lung cancer patients.
    Iizasa T, Fujisawa T, Suzuki M, Motohashi S, Yasufuku K, Yasukawa T, Baba M, Shiba M.
    Clin Cancer Res; 1999 Jan 15; 5(1):149-53. PubMed ID: 9918213
    [Abstract] [Full Text] [Related]

  • 11. [Effects of doxycycline on the expression of matrix metalloproteinase and tissue inhibitor of MMP in myocardium after acute myocardial infarction: an animal experiment with rats].
    Zhang P, Yang YJ, Chen X, Ruan YM, Zhou YW, Tian Y, Chen ZJ.
    Zhonghua Yi Xue Za Zhi; 2004 Aug 02; 84(15):1288-93. PubMed ID: 15387968
    [Abstract] [Full Text] [Related]

  • 12. [Prediction of malignant transformation of hydatidiform mole by mRNA determination of matrix metalloproteinases and tissue inhibitor of metalloproteinases].
    Li Z, Xiang Y, Dai L.
    Zhonghua Fu Chan Ke Za Zhi; 2000 Sep 02; 35(9):547-50. PubMed ID: 11775947
    [Abstract] [Full Text] [Related]

  • 13. [Expression and clinical significance of MMP-2, MMP-9,TIMP-1, and TIMP-2 in breast carcinoma].
    Fan SQ, Wei QY, Li MR, Zhang LQ, Liang QC.
    Ai Zheng; 2003 Sep 02; 22(9):968-73. PubMed ID: 12969531
    [Abstract] [Full Text] [Related]

  • 14. Significance of methylation status and the expression of RECK mRNA in lung tissue of patients with NSCLC.
    Pesta M, Kulda V, Topolcan O, Safranek J, Vrzalova J, Cerny R, Holubec L.
    Anticancer Res; 2009 Nov 02; 29(11):4535-9. PubMed ID: 20032402
    [Abstract] [Full Text] [Related]

  • 15. Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury.
    Yang K, Palm J, König J, Seeland U, Rosenkranz S, Feiden W, Rübe C, Rübe CE.
    Int J Radiat Biol; 2007 Oct 02; 83(10):665-76. PubMed ID: 17729161
    [Abstract] [Full Text] [Related]

  • 16. [The role of disequilibrium of expression of matrix metalloproteinase-2/9 and their tissue inhibitors in pathogenesis of hyperoxia-induced acute lung injury in mice].
    Zhang XF, Zhu GF, Liu S, Foda HD.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Oct 02; 20(10):597-600. PubMed ID: 18926070
    [Abstract] [Full Text] [Related]

  • 17. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
    Wei QY, Wu YQ, Fan SQ.
    Hunan Yi Ke Da Xue Xue Bao; 2003 Jun 02; 28(3):212-6. PubMed ID: 14653069
    [Abstract] [Full Text] [Related]

  • 18. [Involvement of matrix metalloproteinase-2, -9, and tissue inhibitors of metalloproteinase-1, 2 in occurrence of the accrete placenta].
    Ke Y, Lu JH, Yang BL, Guo HQ, Ma QY, Zhu H, Shu HM, Li DJ.
    Zhonghua Fu Chan Ke Za Zhi; 2006 May 02; 41(5):311-4. PubMed ID: 16762185
    [Abstract] [Full Text] [Related]

  • 19. [Comparison of doxycycline, losartan, and their combination on the expression of matrix metalloproteinase, tissue inhibitor of matrix metalloproteinase, and collagen remodeling in the noninfarcted myocardium after acute myocardial infarction in rats].
    Zhang P, Yang YJ, Chen X, Ruan YM, Zhou YW, Tian Y, Chen ZJ.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb 02; 27(1):53-61. PubMed ID: 15782494
    [Abstract] [Full Text] [Related]

  • 20. Biological and clinical significance of MMP-2, MMP-9, TIMP-1 and TIMP-2 in non-small cell lung cancer.
    Iniesta P, Morán A, De Juan C, Gómez A, Hernando F, García-Aranda C, Frías C, Díaz-López A, Rodríguez-Jiménez FJ, Balibrea JL, Benito M.
    Oncol Rep; 2007 Jan 02; 17(1):217-23. PubMed ID: 17143501
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.